Singapore
The company has started to explore “open-loop” financial services, Hungate said in an interview.
1
Partners Group plans full exit from HK-listed Green Tea Group
2
Japan's TEPCO draws interest from SoftBank, PE giants; may raise $6.3b
3
Mubadala's assets jump 17% in 2025 to $385b; to target AI, robotics
4
Singapore’s BIOBOT Surgical secures S$10m, ClavystBio joins cap table
5
Pluckk raises $10.8m led by Euro Gulf Investment and other India deals
More Stories
Vietnam’s MoMo starts sale process including M&A option
After SariWangi, Unilever Indonesia looks to divest Buavita juice brand
Temasek-backed Xora appoints Eric Rosenblum as US general partner
India’s Motilal Oswal Alts open to buyouts with new $938m PE fund
Temasek Trust’s C3H anchors funding in SG healthtech injewelme
Greater China
The EU had pressed China over a surge of dangerous products that entered the bloc.
The deal may contribute $60m incremental Adjusted EBITDA in 2028.
Indonesia
The company posted gains linked to its investment in Allo Bank.
The firm’s story of approaching profitability is being powered by its financial services division.
India
The company is aiming to list in Mumbai before March 2027.
Despite this turnaround, the market’s reaction echoed that of the 2023 sell-off.
Revenue for the full year increased 36.3% to $22.9 billion from $16.8 billion in 2024.
Unilever Ventures also doubled down on its existing investment in RAS.
Current investors Shastra VC, Antler India, and Gemba Capital joined the round.
